Abiomed Submits 510(k) For Impella Ventricular Assist Device
This article was originally published in The Gray Sheet
Executive Summary
Abiomed hopes to gain FDA market clearance of its Impella 2.5 minimally invasive ventricular assist device later this year following the firm's recent 510(k) submission, announced Feb. 5